Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OD-PHOENIX for Knee Osteochondral Lesions
NCT02430558Phase 2Terminated
- Sponsor
- TBF Génie Tissulaire
- Start
- Apr 2016
- Primary completion
- Jun 2021
- Modality
- Tissue Cells
01
Overview
A Phase 2 trial of OD-PHOENIX in knee osteochondral lesion (OCL), sponsored by TBF Génie Tissulaire. Started Apr 2016; status: terminated.
02
Drugs
OD-PHOENIX
03
Conditions
knee osteochondral lesion (OCL)
Beyond the preview
Go deeper on NCT02430558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02430558.